Talking speed crucial for assessing cognitive health in older adults, study finds

As we get older, we may start to notice it takes us longer to find the right words. This can lead to concerns about cognitive decline and dementia.

Pharmalittle: We’re reading about generic weight loss drugs, anxiety over a Sanofi deal, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially after a lengthy weekend respite. Of course, we have returned

October 15, 2024

HLTH23: 6 Digital Health Executives Share Key Takeaways

We reached out to six digital health executives for their key takeaways and reflections from attending the recent HLTH23 conference. Patches Seely MBA, BSN, RN,

October 20, 2023

AstraZeneca lands FDA approval for AKT inhibitor in biomarker-defined breast cancer subset

AstraZeneca has scored an FDA approval for its AKT inhibitor capivasertib, adding a new targeted therapy to its treatment offerings in breast cancer. The drug,

November 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.